Digital Health, Telehealth & Healthcare AI Marketing, Strategy & Growth Consulting
Healthcare does not become digital because somebody added video visits, an app and an AI button. It becomes digital when technology changes how a patient gets access, how a clinician makes a decision, how data moves, how care continues between encounters—or how much friction the system quietly removes from everybody's day.
I help digital-health companies, virtual-care organizations, telehealth practices, remote-monitoring businesses, healthcare SaaS companies, AI-enabled health platforms, hospital innovation teams and connected-care organizations turn that operational reality into positioning, go-to-market strategy, AI search, SEO, enterprise demand, patient acquisition, websites, content, adoption and measurable growth.
Virtual care, software, AI and connected devices are tools. The product is the better care pathway, workflow or business result they make possible.
The most important digital-health question is not “What can the technology do?” It is “What changes for the human being using it?”
Does the patient get seen sooner? Does the nurse spend less time chasing data? Does the physician receive information that changes a decision? Does the hospital avoid an unnecessary visit? Does the therapy team know what happened between sessions? Does the patient actually understand what to do next?
That is the standard I use because digital health is unusually good at producing activity that looks like value. Another dashboard, another alert, another risk score, another portal, another inbox and another AI-generated summary can all be technically successful while making the work harder.
The strongest organizations connect technology to a clearly defined care or operational problem. Then marketing can explain something meaningful: who the product is for, where it belongs in care, why it is credible, how it integrates, how it gets paid for, what implementation requires and what changes when people actually use it.
From virtual visits to generative AI—and the healthcare system between them.
The app is not the care model.
A digital-health company can have excellent software and weak economics because nobody decided who pays. A telehealth practice can have demand and terrible clinician utilization because scheduling is broken. A hospital can buy AI that clinicians ignore because it creates alerts without fitting workflow. A remote-monitoring company can enroll thousands of patients and still fail to generate useful clinical action from the data.
I want to find the business constraint before choosing channels. Is the organization trying to acquire patients, sell enterprise software, expand inside hospital accounts, build payer contracts, recruit clinicians, increase completed visits, improve engagement, drive device utilization or prove that a pilot deserves to become a contract?
The digital layer should also reduce a real burden. Healthcare already has enough tabs, passwords and notifications to qualify as an endurance sport. Adding another one needs a better justification than “digital transformation.”
“Healthcare technology company” can mean six completely different revenue engines.
Telehealth is not a Zoom call with a stethoscope somewhere off camera.
Virtual care has to reproduce enough of the clinical relationship—history, examination where feasible, decision-making, documentation, prescription, follow-up and escalation—to be useful for the specific service.
Synchronous video visits
Live audio-video care can support many follow-ups, behavioral-health visits, chronic-disease management and selected evaluations. The suitability depends on specialty, patient, technology, state law, payer and whether an in-person exam or procedure is needed.
Audio-only care
Telephone-based care can improve access for people without reliable broadband, devices or digital literacy. Coverage and regulatory rules are service- and payer-specific. HHS also reminds covered entities that electronically transmitted ePHI can trigger HIPAA Security Rule safeguards for the communication technology used.
Asynchronous / store-and-forward
Photos, questionnaires, histories and other information can be reviewed later rather than requiring everyone to be online simultaneously. Dermatology and selected consultative workflows are obvious examples, but clinical appropriateness still matters.
E-consults
Clinician-to-clinician electronic consultation can extend specialist expertise and potentially avoid unnecessary travel or referrals. The buyer and value story may be the health system rather than the patient.
Messaging and portal care
Secure messaging can support questions, follow-up and longitudinal management. It can also create enormous inbox burden if the workflow, staffing and escalation rules are poorly designed.
Medicare telehealth
CMS maintains the current list of Medicare telehealth services for each calendar year. Policy continues to change through legislation and annual Physician Fee Schedule rulemaking, so permanent marketing copy should avoid treating a temporary flexibility as universal coverage.
Current references: CMS Telehealth, CMS 2026 Telehealth Services List, and HHS OCR Audio-Only Telehealth Guidance.
The strongest digital care models know when not to stay digital.
A virtual-first organization can make digital access the front door while maintaining explicit pathways into labs, imaging, specialists, urgent care, procedures and in-person examinations when the patient needs them.
Virtual primary care
Primary care can use telehealth for access, continuity, prevention and chronic care while still requiring physical examination, testing and local referral pathways. The business may be insurance-based, employer-sponsored, membership or direct pay.
Virtual specialty clinics
Endocrinology, neurology, dermatology, sleep medicine, obesity medicine, menopause care and other specialties can build digital programs around specific conditions. The value is usually continuity and access rather than video itself.
Hybrid practices
Many of the most practical models combine in-person and virtual care. Digital visits can preserve clinician time and patient convenience while office visits handle examination, procedures, testing or moments when the relationship benefits from being physically present.
Care navigation
Navigation platforms help patients understand where to go, what benefits apply and what happens next. Success depends on network accuracy, handoffs and whether the recommendation actually produces care.
Virtual urgent care
Low-acuity conditions can sometimes be evaluated remotely, but escalation rules are part of the product. A good virtual-care brand should be comfortable saying, “This needs to be seen in person.”
Virtual centers of excellence
Employers and payers may contract with focused networks or digital programs around musculoskeletal care, cardiometabolic disease, behavioral health and other expensive conditions. The buyer wants clinical and economic proof, not only utilization.
The technology may be the same. The clinical job is not.
Behavioral health
Telepsychiatry and psychotherapy can materially improve geographic and scheduling access. Privacy, crisis protocols, controlled-substance rules, licensure and continuity still shape the model.
Dermatology
Image-based and live virtual dermatology can support selected lesions, rashes and follow-up, but image quality and the need for dermoscopy, biopsy or examination can change what is appropriate.
Endocrinology & metabolic care
Diabetes, obesity and thyroid care can combine telehealth with labs, CGM, connected devices, medication management, nutrition and longitudinal coaching.
Cardiology
Remote monitoring, blood pressure, rhythm data, weight and post-discharge care can complement virtual follow-up while acute symptoms still require clear escalation.
Neurology
Selected follow-ups, medication management and visual neurologic examination can work remotely, while imaging, procedures, emergencies and complex examinations may require in-person care.
Rehabilitation
PT, OT and SLP can use telehealth and RTM in selected circumstances. CMS currently extends certain Medicare telehealth flexibilities for these therapy professions through December 31, 2027.
Women's health
Contraception, menopause, fertility-adjacent services and postpartum care can use virtual access while preserving pathways for examinations, imaging, laboratory testing and procedures.
Rare disease
Virtual specialist access can reduce travel for geographically dispersed populations and support multidisciplinary care. The challenge becomes coordination across local and specialty teams.
This specialty context connects with my broader Physician & Surgeon Marketing work and Hospital & Health System work.
Remote monitoring is valuable when data create action—not when the dashboard simply proves the patient owns Bluetooth.
CMS describes remote patient monitoring as a model in which a patient collects health data such as blood pressure, weight or glucose using a connected medical device that automatically transmits the information to the healthcare provider, who then uses it to manage care. That definition makes the distinction between genuine connected monitoring and asking a patient to remember a number over the phone.
RPM commonly involves physiologic data. RTM can focus on therapeutic adherence and response, including musculoskeletal and respiratory treatment workflows. CMS added and revised RTM codes for 2026, including new 2–15-day device-supply code options in specified categories.
The business model can look attractive because reimbursement exists, but successful programs still require appropriate patients, setup, device use, data review, clinical action, communication, documentation and enough staffing to keep the monitoring queue from becoming a digital junk drawer.
References: CMS Remote Patient Monitoring, updated May 2026 and CMS 2026 Therapy / RTM Updates.
Hospital at home is not “telehealth, but sicker.” It is hospital-level care delivered through a different operating environment.
CMS launched the Acute Hospital Care at Home initiative in 2020. Congress has now extended the associated waivers and flexibilities through September 30, 2030.
Hospital responsibility remains
Participating hospitals deliver inpatient-level care at home under the initiative's conditions. Remote monitoring, in-person services, medications, escalation, logistics and clinical oversight have to operate as one system.
Technology is infrastructure
Connected devices, communication, command centers, EHR access and monitoring help coordinate care, but the actual product includes people arriving at the home, supplies, pharmacy, labs, transport and emergency escalation.
Patient selection matters
Not every inpatient belongs at home. Clinical criteria, home environment, support, geography and safety determine which patients can be served appropriately.
Logistics become clinical
Delivering medication, oxygen, diagnostics or equipment on time can influence care quality. The boundary between “health tech” and “supply chain” disappears quickly at the front door.
Brand trust matters
Some patients and families love the idea of avoiding a hospital room. Others may worry that home care means less care. Communication has to explain the model rather than assume convenience automatically feels safe.
Health-system strategy
Hospital-at-home programs sit inside broader capacity, bed utilization, emergency department, inpatient, post-acute and population-health strategy—not as isolated innovation projects.
Reference: CMS Acute Hospital Care at Home Data Release Fact Sheet, March 2026.
A wearable can produce thousands of data points and still leave the clinician with one question: now what?
Connected blood pressure
Home cuffs can support hypertension management when measurement technique, transmission, review and treatment workflows are sound. A stream of bad measurements is merely automated confusion.
Continuous glucose monitoring
CGM creates longitudinal glucose information that can support diabetes care and, in some markets, broader metabolic coaching. Clinical interpretation and claims should match the device's intended use and evidence.
Cardiac wearables
Wearable ECG, rhythm monitoring and other sensors can support detection or monitoring in specific contexts. Consumer awareness may be high, but regulatory status and what the measurement actually means remain important.
Sleep technology
Home sleep testing, wearables and consumer devices can estimate or measure different aspects of sleep. Diagnostic claims belong to appropriately validated and regulated functions, not every ring that reports a score.
Movement & rehabilitation sensors
Motion, adherence and activity data can support rehabilitation, fall prevention or performance. RTM and clinical programs may use different technology and evidence than consumer fitness tracking.
Consumer wearables
General wellness features can encourage activity, sleep or awareness without necessarily being medical-device functions. FDA updated its General Wellness guidance in January 2026, reinforcing the importance of intended use.
Connected-device strategy also overlaps my Bio-Optics, Frontier Science and Science Marketing work where sensors, optics, physiological data and emerging technology require real technical explanation.
An app that helps someone feel better is not automatically a medical treatment—and an app intended to treat disease deserves a different level of scrutiny.
Prescription digital therapeutics
Software intended to treat a disease or condition may be a regulated device depending on function and claims. Commercialization can involve clinicians, prescriptions, evidence, reimbursement and patient adherence in addition to app-store UX.
Behavior-change platforms
Digital coaching can support nutrition, activity, sleep, chronic-disease self-management and medication adherence. The more the product claims to diagnose or treat disease, the more important regulatory classification becomes.
General wellness
Low-risk products intended to maintain or encourage a general state of health can fall under FDA's general-wellness policy when they meet the applicable criteria. “Wellness” is not a loophole for making disease-treatment claims without evidence.
Mental-health apps
Meditation, journaling and coaching apps differ from clinical psychotherapy, psychiatric treatment and regulated software functions. A clear boundary can strengthen trust instead of weakening the product.
Musculoskeletal digital care
Exercise programs, virtual PT, coaching, sensors and RTM can support musculoskeletal care. The clinical professional, therapeutic claim and reimbursement model determine how the service should be described.
Digital adherence
Reminders, education and behavior support can help patients follow treatment plans. An adherence metric is useful only if the system understands why the person stopped engaging.
FDA's current digital-health guidance collection includes the January 2026 General Wellness and Clinical Decision Support updates.
Healthcare AI is not one product category. It is a family argument among statistics, software, medicine, workflow and regulation.
I separate administrative AI, clinical-support AI and regulated device AI because they carry different evidence and governance burdens.
Scheduling & access AI
Systems can route calls, identify appointment intent, predict no-shows, manage waitlists and help patients find services. The commercial value is access and staff efficiency; the risk is sending the wrong person to the wrong place with great confidence.
Documentation AI
Ambient listening, transcription and note drafting can reduce clerical burden. Accuracy, patient disclosure, recordings, retention, sensitive content and clinician review determine whether saved time is actually safe time.
Inbox & message drafting
AI can summarize or draft patient communications. Systems need escalation rules because a routine refill request and a hidden emergency can arrive through the same inbox.
Coding & revenue cycle
AI can assist coding, documentation review, denials and revenue-cycle workflows. Automation should support defensible billing rather than create a faster route to confidently incorrect claims.
Prior authorization
Automation can organize clinical evidence, identify requirements and reduce administrative work. The patient experience still depends on whether the care ultimately gets authorized and delivered.
Clinical decision support
Risk prediction, differential support, treatment recommendations and other clinical outputs can cross into regulated or certified-health-IT territory depending on function. The label “decision support” does not decide the law.
Imaging AI
Radiology is heavily represented on FDA's AI-enabled medical-device list. Products may assist detection, measurement, reconstruction, triage or other authorized functions rather than replace radiologists wholesale.
Pathology & diagnostics AI
Digital pathology, lab interpretation and diagnostic algorithms can help identify or quantify features. Data quality, intended population, validation and workflow integration are part of the product.
Population health AI
Risk stratification can identify patients who may need outreach or additional care. Model performance across populations and whether the healthcare system has capacity to act on the list both matter.
Pharmacy & medication AI
Medication reconciliation, adherence, interaction review and workflow automation can support clinicians and pharmacists. Medication recommendations have obvious consequences when the model is wrong.
Research & drug development AI
AI can support literature analysis, trial operations, biomarker discovery and drug development. That belongs partly in life sciences, but digital-health companies may supply the infrastructure.
Patient-facing AI
Symptom tools, navigation bots and conversational systems can improve access to information. The interface should make it obvious when the system is educational, administrative or providing a regulated medical function.
Generative AI is good at producing language. Healthcare is full of situations where one wrong sentence matters.
That does not make generative AI unusable. It makes architecture, retrieval, validation, human review and role boundaries part of the product.
Ambient clinical documentation
Ambient systems can capture clinician-patient conversation and draft documentation. Organizations should think about consent, recording, retention, third-party data handling, hallucination, omission and the clinician's responsibility to review the final note.
Clinical summarization
LLMs can summarize long charts, discharge histories or messages. The risk is not only fabricated content; omission and emphasis can change interpretation too.
RAG & grounded assistants
Retrieval-augmented systems can constrain answers to selected knowledge sources and show citations. That can improve traceability, but source quality, retrieval failure and outdated policy still matter.
Patient communication
AI can draft education and follow-up content in plain language and multiple languages. Translation quality, medical accuracy and cultural context should be reviewed rather than assumed.
Internal copilots
Clinical and administrative teams can use assistants for policies, knowledge retrieval and workflow support. Access controls matter because the easiest way to build a useful chatbot is often to connect it to information that should not be visible to everyone.
Regulatory frontier
On August 18, 2026, FDA issued a discussion paper seeking public feedback on regulatory considerations for generative-AI-enabled medical devices, including risk assessment, premarket evaluation and postmarket monitoring. That is a discussion process, not a blanket approval framework.
Current reference: FDA discussion paper announcement on generative-AI-enabled medical devices, August 18, 2026.
The regulatory question begins with function and intended use—not whether the product has an AI logo.
Non-device CDS can exist
FDA's January 2026 Clinical Decision Support guidance explains that certain CDS software functions can meet statutory criteria excluding them from the device definition. Other CDS functions remain device software.
Patient-facing functions matter
FDA specifically notes that its digital-health policies continue to apply to software functions meeting the device definition, including functions intended for patients or caregivers. “The user is a patient” does not make the regulatory question disappear.
AI-enabled device list
FDA maintains a public list of AI-enabled medical devices authorized for U.S. marketing. FDA also states the list is not comprehensive and continues refining how modern AI, including foundation-model and LLM functionality, can be identified transparently.
PCCPs
FDA's final guidance on Predetermined Change Control Plans describes how certain planned modifications to AI-enabled device software functions can be included in a marketing submission, supporting controlled evolution without assuming every model update is automatically acceptable.
Adaptive AI
AI-enabled device software may change over time. The commercial narrative should distinguish what was authorized, what changes are planned and how performance is monitored rather than treating “learning” as a self-validating feature.
Regulatory vocabulary
Cleared, approved, authorized, certified, listed and HIPAA compliant are not interchangeable status words. Digital-health companies can lose trust quickly by stacking them into one badge wall.
References: FDA Clinical Decision Support Software, January 2026, FDA AI-Enabled Medical Devices, and FDA AI-Enabled Device PCCP Guidance.
“Human in the loop” is not a governance plan if the human cannot realistically catch the error.
Intended use
Define what the model is supposed to do, for whom, in which workflow and which decisions it may influence. Ambiguity at this stage creates downstream risk everywhere.
Validation
Evaluate performance against the actual task, population and deployment context. A model can perform well in development and poorly after workflow, data or population shifts.
Bias & fairness
Training data can encode disparities or omit populations. Performance should be evaluated across relevant groups where appropriate rather than assuming one aggregate metric settles the question.
Monitoring
Model drift, software changes, practice changes and new data can alter performance. Ongoing monitoring turns governance from a launch document into an operating system.
Escalation
When confidence is low, data are missing or the situation is high risk, the system should have a sensible path to a qualified person rather than improvising through uncertainty.
Transparency
Users need enough information to understand what a prediction or recommendation means and where its limitations lie. In certified health IT, ONC's HTI-1 rule created algorithm-transparency requirements for predictive decision support supplied through certified modules.
ONC's HTI-1 framework uses the useful concept of evaluating predictive decision support for whether it is fair, appropriate, valid, effective and safe. That is not a complete AI-governance program, but it is a much better starting question than “Does it have AI?”
Reference: ONC HTI-1 Final Rule.
The healthcare system does not need more data trapped inside prettier boxes.
Digital health has to coexist with EHRs, patient portals, labs, imaging, pharmacies, claims, HIEs and an expanding network of APIs and exchange frameworks.
EHR integration
Single sign-on, embedded workflows, SMART-on-FHIR apps, orders, results, documentation and context can reduce tab switching and duplicate work. Integration effort is often part of the sales cycle.
FHIR
FHIR is a widely used standard for exchanging healthcare information through structured resources and APIs. Saying “FHIR-enabled” is only useful if the company can explain which data and workflows are actually supported.
USCDI
ONC's HTI-1 rule made USCDI Version 3 the baseline for certified health IT beginning January 1, 2026. Interoperability standards continue evolving as more data classes and use cases become important.
Information blocking
Federal information-blocking rules address practices likely to interfere with access, exchange or use of electronic health information unless an exception applies. Product strategy should not treat data access as merely a competitive preference.
TEFCA
The Trusted Exchange Framework and Common Agreement supports nationwide health-information exchange among participating networks. The commercial question for vendors is how exchange improves the workflow, not how many interoperability acronyms fit on the homepage.
Patient access
Patients increasingly expect digital access to records, results, scheduling and communication. Access is useful when information is understandable and the next clinical step is clear.
Reference: ONC Interoperability Resources and HTI-1.
Patients do not care which department owns the portal. They care whether they can get an appointment.
Online scheduling
Self-scheduling can reduce friction when appointment types, eligibility, insurance, location and urgency rules are designed correctly. Bad scheduling automation simply lets patients book the wrong visit faster.
Provider discovery
Search, directories and AI navigation should help patients find the right specialty, clinician, location and service—not merely route everyone toward the next available calendar slot.
Patient portals
Portals can centralize messages, results, records, forms, billing and appointments. Adoption depends on access, usability, notifications and whether patients understand what requires action.
Automated outreach
Reminders, recalls, preventive-care prompts and follow-up can improve continuity. Too much automation creates message fatigue and teaches people to ignore the system.
Care navigation
Navigation can connect benefits, network, clinical need and local availability. It becomes especially valuable in complex specialties, chronic disease and large health systems.
Accessibility & digital divide
Older adults, people with disabilities, rural patients, low-bandwidth households and people with limited English proficiency may experience digital care differently. Telephone, captions, language access and human support remain part of digital design.
“Not covered by HIPAA” does not mean “health data has no rules.”
Digital health lives across HIPAA-regulated providers and business associates, consumer apps, connected devices, advertising systems and vendors that may be governed by different federal and state rules.
HIPAA-covered environments
Covered entities and business associates have obligations under the HIPAA Privacy, Security and Breach Notification Rules when handling PHI. A vendor saying it is “HIPAA compliant” does not make the customer compliant by installation.
Telehealth technology
HHS states that covered providers and plans using telehealth need to comply with applicable HIPAA requirements and use vendors that will enter appropriate business associate agreements when the vendor is acting as a business associate.
Website and app tracking
OCR's tracking-technology bulletin addresses PHI disclosures through websites and mobile apps, including authenticated areas and app data. A federal court vacated a portion of OCR's guidance regarding certain unauthenticated webpages in 2024, so current implementation should reflect the surviving guidance and qualified legal review.
FTC Health Breach Notification Rule
The FTC's 2024 final amendments clarify the Health Breach Notification Rule's applicability to certain health apps and similar technologies outside HIPAA and address unauthorized disclosures as well as security breaches.
Advertising data
Pixels, SDKs, retargeting, session replay and audience tools can create risk when health information or patient behavior is disclosed inappropriately. Marketing architecture should be reviewed before adding familiar ad-tech code by habit.
Consent is not a banner
OCR specifically notes that an ordinary website cookie banner does not itself constitute HIPAA authorization for a PHI disclosure. Privacy choices need to match the law and data flow, not the visual style of the popup.
References: HHS OCR Tracking Technologies Guidance, HHS HIPAA & Telehealth, and FTC Health Breach Notification Rule.
A virtual-care platform can be clinically convenient and operationally catastrophic if nobody owns security.
Identity & access
Authentication, role-based access, MFA and account lifecycle matter because healthcare platforms contain information that should not be visible merely because someone still has an old login.
Cloud & vendors
Digital-health stacks often rely on cloud infrastructure, APIs, communications tools, analytics and AI vendors. Security and privacy obligations travel through the vendor chain.
Connected devices
Devices can introduce network, update and vulnerability-management concerns. Medical-device cybersecurity carries additional FDA expectations for relevant products.
Availability
Security is not only confidentiality. A telehealth, monitoring or hospital-at-home system that is unavailable during care has a clinical-operational problem.
Incident communication
Security events can become patient-trust, customer-retention and regulatory events at once. Communication plans should exist before the incident decides to write one for the company.
Marketing restraint
I do not tell healthcare companies that buying a particular platform makes them HIPAA compliant, secure or compliant with every state privacy rule. Those are organizational responsibilities, not software adjectives.
Healthcare cybersecurity deserves its own deep treatment because identity, ransomware, cloud infrastructure, security operations and health-data architecture are broader than a single digital-health section.
The pilot is not the sale. The sale is not adoption. Adoption is not renewal.
Healthcare SaaS can spend a year winning a contract and then discover the hardest commercial moment begins after signature.
Clinical champion
A respected physician, nurse or operational leader can help translate the problem and defend the implementation when friction appears.
IT & security
Integration, identity, architecture, data flow, security review and support can determine timeline long before the end user sees the software.
Finance & procurement
Per-member, per-provider, subscription, usage, implementation and outcome-linked pricing create different economic questions. The buyer needs to understand total cost and measurable value.
Change management
Training alone does not fix a workflow people dislike. Good implementation understands incentives, time, champions, superusers and what old process has to stop.
Customer success
In healthcare, customer success may need to understand clinical operations, not simply product adoption. A low-login account may be a churn risk—or a sign the workflow was designed to be invisible.
Land and expand
A successful department, facility or population can create expansion into more service lines or sites. Expansion should follow demonstrated value rather than an arbitrary upsell calendar.
The software-business side connects with my SaaS Marketing work; healthcare changes the buying committee, evidence, privacy and implementation stakes.
Digital-health search is full of buyers who do not use the company's preferred category name.
Patient intent
People search symptoms, services, virtual doctors, medication questions, remote care and how to get help. The content should route to appropriate care rather than optimize fear.
Clinical intent
Clinicians may search evidence, integrations, workflow, devices, reimbursement, specialty applications or implementation questions.
Enterprise intent
Health-system buyers search platform categories, vendors, security, integration, case studies, pricing logic, outcomes and implementation proof.
Technical intent
Developers and informatics teams search APIs, FHIR, EHR integrations, SSO, data models, security and SDK documentation. Technical docs can be acquisition content.
AI answer visibility
Answer systems need clear entity relationships: product, intended user, clinical function, regulatory status, integrations, evidence, specialties and pricing or buyer model where public.
Category formation
Emerging health tech often lacks stable terminology. Good content can help define the problem and category without inventing a new three-letter acronym every Tuesday.
The acquisition channel should match whether the buyer is a patient tonight or a hospital next fiscal year.
Patient paid search
Telehealth can capture high-intent demand around access, specialty and condition queries. Conversion quality matters because the wrong patient, wrong state, wrong insurance or wrong clinical need wastes media and clinician time.
Enterprise ABM
Healthcare SaaS and AI vendors often know which systems, payers or practices are plausible accounts. Account strategy can combine executive content, clinical proof, professional media, search, events and sales outreach.
Employer / payer campaigns
Digital-health vendors selling population solutions need economic, utilization and outcomes stories for benefits leaders and health plans rather than consumer-style product marketing.
Clinician adoption
HCP campaigns can support awareness and education, but adoption usually depends on workflow, evidence and local implementation—not ad frequency alone.
Conference strategy
HIMSS, HLTH, ViVE, specialty congresses and other events can concentrate buyers and partners. Pre-event meetings and post-event progression matter more than booth traffic.
Privacy-aware media
Health-condition targeting, pixels and remarketing require disciplined privacy review. A campaign can be beautifully optimized and still be a terrible idea.
The website should answer what the product does without making everybody sit through the demo first.
Product explanation
Show the problem, user, workflow, output and outcome. Screenshots are useful after the visitor understands why the screen deserves to exist.
Audience paths
Patients, providers, hospital executives, IT, payers, employers, partners and investors may need separate entry points into the same company story.
Evidence
Peer-reviewed studies, validation, regulatory status, case studies and outcomes should be connected to the exact product and use case they support.
Integration proof
EHRs, APIs, FHIR, SSO, devices and workflow integrations should be described concretely enough for technical evaluators to understand feasibility.
Trust center
Security, privacy, compliance information, subprocessors and documentation can support enterprise diligence when maintained accurately.
Thought leadership
Founders, clinicians, informaticists, engineers and operators can build authority around problems the market is still learning to name. The smartest content teaches before it sells.
Explore integrated digital strategy, websites, search and paid media →
Downloads and demos are intermediate events. Digital health ultimately has to survive utilization.
| Metric | What it can tell me | What it cannot tell me alone |
|---|---|---|
| Booked-to-completed visits | Whether virtual-care access converts into actual clinician encounters. | Clinical appropriateness, patient outcome or margin. |
| Activation | Whether patients or clinicians get through onboarding and begin using the product. | Durable value or correct use. |
| Weekly / monthly active clinical users | Whether a workflow is becoming habitual for intended users. | Whether frequent use is beneficial or simply required by poor design. |
| RPM / connected-device adherence | Whether data continue to flow from enrolled patients. | Whether clinicians act on the data. |
| Clinical action rate | Whether monitoring or decision-support outputs produce meaningful review or intervention. | Appropriateness or downstream outcome. |
| Enterprise pilot conversion | Whether evaluations become paid deployments. | Renewal or expansion after implementation. |
| Net revenue retention | Whether enterprise customers renew and expand financially. | Clinical value or customer concentration risk. |
| Clinician minutes saved | Potential operational value of AI or workflow automation. | Accuracy, safety or whether the saved time becomes usable capacity. |
Digital care can cross distance. Licensure, networks, broadband, hospitals and people remain stubbornly geographic.
Central Florida & Florida
Florida combines large healthcare demand, older adults, seasonal residents, rural communities, major health systems and rapid population growth. Telehealth can improve access across distance while state licensure, payer networks and local escalation pathways still shape delivery.
Rural & underserved markets
Virtual care can reduce travel and extend specialist access, but broadband, device access, digital literacy, language and local care capacity determine whether the theoretical access becomes real access.
National enterprise markets
Digital-health companies may sell nationally while implementation happens health system by health system. A product can be technically location-independent and commercially dependent on dozens of local workflows.
Geography supports the business context here; it does not replace the national digital-health expertise.
Bring me the workflow before the feature list.
Maybe the telehealth company is buying patient leads but completion is weak. Maybe the health-system AI pilot has plenty of executive attention and no clinician adoption. Maybe the SaaS company is technically integrated but nobody can explain the economic value. Maybe the remote-monitoring program enrolls patients faster than staff can manage the data. Maybe the founder has built a very clever health app and has not yet decided whether it is wellness software, clinical decision support or a medical-device function.
I work comfortably across marketing, healthcare, AI, digital technology, science and business strategy, which is useful because digital health sits directly in the overlap. I can work with founders, clinicians, informatics leaders, hospital executives, product teams, investors, marketing leaders and technical operators without forcing all of them into the same vocabulary.
I do not provide medical, legal, regulatory, cybersecurity, privacy or reimbursement advice. I do make the marketing and growth strategy intelligent enough to know when those disciplines have to be in the room.
Digital health, telehealth & healthcare AI marketing FAQs
The useful questions usually begin with the clinical job, user and business model before they reach the technology stack.
What does a digital health marketing consultant do?
I help digital-health, telehealth, healthcare AI and virtual-care organizations connect market positioning, patient or enterprise acquisition, AI search, SEO, product marketing, websites, paid media, implementation, adoption and measurement to the actual healthcare workflow and business model.
What is the difference between digital health and telehealth?
Telehealth is one part of digital health and generally refers to health services delivered or supported through telecommunications technology. Digital health is broader and can include remote monitoring, connected devices, health IT, patient engagement, software, AI, digital therapeutics and other technology-enabled healthcare.
Do you work with telemedicine practices?
Yes. Telemedicine strategy can address patient acquisition, specialty positioning, scheduling, state and payer geography, visit completion, clinician capacity, follow-up, retention, SEO, paid search and hybrid-care pathways while leaving medical and licensure decisions to qualified professionals.
Can you help virtual primary care companies?
Yes. Virtual primary-care growth can involve member or patient acquisition, insurance or employer channels, clinician utilization, labs, referrals, longitudinal engagement and clear in-person escalation pathways.
Can you help virtual specialty-care companies?
Yes. Digital specialty programs can include behavioral health, dermatology, endocrinology, cardiometabolic care, women's health, neurology, sleep, obesity medicine and other areas where virtual care can support access and longitudinal management.
Can you help telepsychiatry and virtual behavioral health companies?
Yes. Behavioral telehealth can improve access and continuity, but strategy should also account for clinician supply, privacy, crisis escalation, state practice rules, payer networks and the difference between clinical care and consumer mental-wellness apps.
Can you help remote patient monitoring companies?
Yes. RPM strategy can cover physician or health-system acquisition, patient enrollment, connected-device activation, data transmission, clinical action, staffing, reimbursement-aware workflows, retention and the economics of managing monitored populations.
How does CMS define remote patient monitoring?
CMS describes RPM as a model in which patients collect physiologic health data using connected medical devices that automatically transmit the information to healthcare providers, who use the data to treat or manage the patient's condition.
What is the difference between RPM and RTM?
Remote physiologic monitoring generally focuses on physiologic data such as blood pressure, weight or glucose. Remote therapeutic monitoring can focus on therapeutic adherence and response in specified treatment categories. Coding, device and billing requirements differ and should be reviewed under current CMS and payer guidance.
Can physical therapists use telehealth and RTM under Medicare in 2026?
CMS states that current federal law extends the ability of PTs, OTs and SLPs to furnish specified Medicare telehealth services through December 31, 2027, and CMS added or revised several RTM codes for 2026. Exact billing depends on the service and current requirements.
Can you help hospital-at-home programs?
Yes. Hospital-at-home strategy can support patient and physician education, service-line positioning, referral pathways, digital infrastructure communication, remote-monitoring adoption and health-system growth. The clinical and operational model remains much broader than telehealth alone.
How long is the CMS Acute Hospital Care at Home initiative currently extended?
Congress extended the waivers and flexibilities associated with CMS's Acute Hospital Care at Home initiative through September 30, 2030.
Can you help connected-device and wearable health companies?
Yes. Strategy can cover connected blood-pressure devices, glucose monitoring, cardiac wearables, sleep technology, movement sensors, remote monitoring and other connected products. Claims should match the device's actual intended use, regulatory status and evidence.
Can you help digital therapeutics companies?
Yes. Digital-therapeutic commercialization can involve clinicians, evidence, regulatory status, reimbursement, patient onboarding, engagement and adherence. Software intended to treat disease has a different regulatory and commercial context from ordinary general-wellness software.
What is the difference between a wellness app and regulated medical software?
The distinction depends on intended use and function. FDA has a general-wellness policy for certain low-risk products, while software intended to diagnose, treat, prevent or otherwise perform medical-device functions may fall within device regulation. Product-specific classification should be reviewed by qualified regulatory professionals.
Can you help healthcare AI companies?
Yes. I can help with positioning, GTM, AI search, content, enterprise demand, websites and adoption for healthcare AI used in administrative workflows, documentation, navigation, clinical decision support, imaging, diagnostics, revenue cycle, population health and other areas.
Can you help ambient clinical AI and AI scribe companies?
Yes. Ambient documentation products need to explain clinician time savings, workflow, note quality, integration, privacy, consent, data retention and human review. The product should not be marketed as replacing clinician responsibility for the final medical record.
Can you help generative AI companies in healthcare?
Yes. Generative AI can support summarization, documentation, patient communication, knowledge retrieval and other workflows. Product strategy should account for hallucination, omission, grounding, source quality, access controls, human review and whether a particular function is regulated.
Is FDA currently looking at generative AI medical devices?
Yes. On August 18, 2026, FDA issued a discussion paper seeking public feedback on regulatory considerations for generative-AI-enabled medical devices, including risk assessment, premarket evaluation and postmarket monitoring. It is a discussion process, not a blanket authorization framework.
Does FDA maintain a list of AI-enabled medical devices?
Yes. FDA maintains a public list intended to identify AI-enabled medical devices authorized for U.S. marketing. FDA states the list is not comprehensive and continues working on clearer identification of newer AI technologies such as foundation-model and LLM-based functionality.
Can all clinical decision support software avoid medical-device regulation?
No. FDA's January 2026 Clinical Decision Support guidance explains that certain CDS functions can meet statutory criteria excluding them from the device definition, while other CDS software remains a regulated device function.
What is SaMD?
Software as a Medical Device generally refers to software intended to perform one or more medical purposes without being part of a hardware medical device. Software that drives or controls hardware has a different relationship to the device.
What is a predetermined change control plan for AI medical devices?
A PCCP can describe certain planned modifications to an AI-enabled device software function and the methods for developing, validating and implementing those modifications. FDA can review the PCCP as part of a marketing submission, allowing authorized changes within the reviewed plan when applicable.
Can you help healthcare organizations with AI governance?
Yes, from the strategic and operational side. I can help define use cases, roles, workflow, review processes, model documentation, measurement and governance questions. Formal legal, regulatory, privacy, security and clinical validation decisions remain with the appropriate professionals.
What does ONC's HTI-1 rule mean for healthcare AI?
HTI-1 created algorithm-transparency requirements for predictive decision support interventions supplied through certified health IT and requires relevant risk-management practices and source information. ONC frames trustworthy predictive DSI evaluation around whether systems are fair, appropriate, valid, effective and safe.
Can you help EHR and interoperability companies?
Yes. Health IT strategy can cover EHR-connected apps, FHIR APIs, workflow integration, patient access, portals, exchange, information blocking context, product marketing and enterprise implementation.
What is FHIR?
FHIR is a healthcare interoperability standard that structures health information into resources and supports modern API-based exchange. For commercial strategy, the important question is which data, users and workflows a product can actually support through FHIR.
What is USCDI Version 3?
The United States Core Data for Interoperability Version 3 became the baseline standard within the ONC Health IT Certification Program on January 1, 2026 under the HTI-1 final rule.
Can you help patient-portal and digital-front-door companies?
Yes. Strategy can include online scheduling, provider search, forms, navigation, messaging, records access, patient engagement and conversion. The best digital front door helps people reach appropriate care rather than merely adding more self-service.
Is telehealth automatically HIPAA compliant?
No. HIPAA compliance is an organizational responsibility. Covered entities and business associates must meet applicable Privacy, Security and Breach Notification Rule requirements, use appropriate vendors and business associate agreements where required, and manage the full data flow.
Do HIPAA rules apply to every health app?
No. HIPAA applies to covered entities and business associates in applicable relationships. Consumer health apps outside HIPAA may still be subject to other laws, including the FTC Act, the FTC Health Breach Notification Rule and state privacy laws.
What is the FTC Health Breach Notification Rule?
The FTC rule requires certain vendors of personal health records and related entities to notify consumers and others after breaches of unsecured identifiable health information. The FTC's 2024 amendments clarified the rule's applicability to health apps and similar technologies outside HIPAA.
Can healthcare organizations use website tracking pixels?
The answer depends on the data, page, entity and vendor relationship. HHS OCR has guidance on tracking technologies for HIPAA-regulated entities, including authenticated pages and mobile apps, and part of its guidance concerning certain unauthenticated public pages was vacated by a federal court in 2024. This area deserves current privacy and legal review before implementation.
Can a cookie banner serve as HIPAA authorization?
HHS OCR states that an ordinary website banner asking a user to accept or reject tracking technologies does not itself constitute a valid HIPAA authorization for disclosure of PHI.
Can you help healthcare SaaS companies sell to hospitals?
Yes. Enterprise healthcare sales can involve clinical champions, IT, security, procurement, finance, legal, privacy, integration and end users. Strategy should address the full pilot-to-contract-to-adoption-to-renewal cycle rather than treating the demo as the finish line.
Can you help digital health companies with ABM?
Yes. Account-based marketing is often effective when the real buyer universe is a defined set of health systems, payers, employers, practices or enterprise partners. It can combine account research, executive content, clinical proof, search, professional media, events and sales outreach.
Can you provide SEO for digital health and telehealth companies?
Yes. Search strategy can cover patient conditions, virtual services, technology categories, reimbursement questions, clinical workflows, integrations, technical documentation and enterprise buyer intent while keeping medical and regulatory claims accurate.
Can you help digital health companies appear in AI search?
Yes. GEO, AEO and AI Search Optimization can clarify product category, intended user, clinical function, regulatory status, evidence, integrations, specialties and buyer model so generative systems can represent the company more accurately.
Can you manage PPC for telehealth companies?
Yes. Paid search can capture high-intent patient demand, but campaigns should account for specialty, geography, clinician capacity, insurance, visit appropriateness, health-data privacy and conversion all the way through completed care.
Can you redesign a digital-health or healthcare-SaaS website?
Yes. I can structure patient, clinician, enterprise, technical, security, evidence, integration and investor content so each audience reaches the right depth. WordPress works well for many organizations, while some regulated or enterprise environments require other stacks.
Do you only work with digital-health companies in Florida?
No. Paper Boat Media is based in DeLand, Florida, and I understand Florida and Central Florida healthcare markets particularly well, but digital health, telehealth and healthcare AI are national and often global markets. Geography matters when it changes licensure, payer networks, hospital systems, broadband or clinical access.
Can you work as a consultant, fractional CMO or hands-on digital health marketing partner?
Yes. Engagements can range from focused positioning, AI-search or product-marketing projects to retained advisory, fractional CMO leadership and hands-on execution across websites, content, paid media, ABM, patient acquisition and analytics.
What should I bring to an initial digital health strategy conversation?
Bring the product, care model, buyer, user, current regulatory or reimbursement context, integrations, evidence, adoption data and the point where growth is getting stuck. A product deck is useful, but the workflow is usually more interesting.
Tell me what the technology is supposed to make better.
Maybe the telehealth practice needs completed visits instead of leads. Maybe the RPM program needs engagement instead of enrollment. Maybe the hospital AI pilot needs clinician adoption. Maybe the digital-health startup has three buyers and one homepage. Maybe the product is medically impressive, technically elegant and commercially impossible to explain.
Bring me the workflow, the user, the buyer and the point where the system is getting stuck. I can work backward from there.